Public Advisories
May 7, 2008
Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug
Toronto, ON. Apotex Inc., Canada's largest generic pharmaceutical company has successfully bid and been awarded a tender from the Rwandan Government for the life saving...
May 7, 2008
Biosimilar G-CSF: Cooperation on Three Continents.
Toronto, ON. A biosimilar protein that can be used to treat neutropenia (a side effect of cancer chemotherapy) is to be developed by Apotex Inc. of Canada in collaboration with Intas Biopharmaceuticals...
December 5, 2007
Apotex, Canada's Largest Generic Pharmaceutical Company Makes 2nd Acquisition in Europe by Purchasing Lareq Pharma of Spain
Toronto, ON. Apotex Inc., announced today that it has acquired Lareq Pharma S.L. of Spain for an undisclosed sum from Industria Quimica Y Farmaceutica VIR S.A...
November 15, 2007
The Largest Canadian-Owned Generic Pharmaceutical Company Acquires Topgen E.S.V. in Belgium from Zambon
Toronto, ON. Apotex Inc., the largest Canadian-owned generic company announced today the purchase from Zambon of the pharmaceutical company, Topgen, E.S.V. of Belgium, No acquisition price was disclosed...
Select a Country
Argentina
Aruba
Australia
Bahamas
Barbados
Belarus
Belgium
Bermuda
Botswana
Canada (English)
Canada (Francais)
Cayman Islands
China
Costa Rica
Curacao
Czech Rep.(English)
Czech Rep.(Cesky)
El Salvador
Guatemala
Guyana
Haiti
Hong Kong
Hungary
Indonesia
Iran
Jamaica
Jordan
Kuwait
Lebanon
Libya
Malaysia
Mexico
Moldova
Netherlands (English)
Netherlands (Nederlands)
Nigeria
Nicaragua
New Zealand
Panama
Philippines
Poland (English)
Poland (Polska)
Russia
Saudi Arabia
Singapore
Spain
Taiwan
Thailand
Trinidad
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Vietnam
Zimbabwe